相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorting out adipocyte precursors and their role in physiology and disease
Chelsea Hepler et al.
GENES & DEVELOPMENT (2017)
Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model
Cristal S. Yee et al.
BONE (2016)
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
Mayumi Ukita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bmp4 Promotes a Brown to White-like Adipocyte Shift
Salvatore Modica et al.
CELL REPORTS (2016)
LRP5 Regulates Human Body Fat Distribution by Modulating Adipose Progenitor Biology in a Dose- and Depot-Specific Fashion
Nellie Y. Loh et al.
CELL METABOLISM (2015)
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism
Giuseppe Daniele et al.
DIABETES CARE (2015)
Wnt-Lrp5 Signaling Regulates Fatty Acid Metabolism in the Osteoblast
Julie L. Frey et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Lipid-Overloaded Enlarged Adipocytes Provoke Insulin Resistance Independent of Inflammation
Jong In Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation
Jieun Lee et al.
CELL REPORTS (2015)
Anorexia nervosa and bone metabolism
Pouneh K. Fazeli et al.
BONE (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Circulating Sclerostin Associated With Vertebral Bone Marrow Fat in Older Men But Not Women
Yu-Heng Vivian Ma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Regulation of Wnt/β-catenin signaling within and from osteocytes
Travis A. Burgers et al.
BONE (2013)
Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner
Nicole M. Collette et al.
DEVELOPMENTAL BIOLOGY (2013)
Diabetes Risk Gene and Wnt Effector Tcf7l2/TCF4 Controls Hepatic Response to Perinatal and Adult Metabolic Demand
Sylvia F. Boj et al.
CELL (2012)
Wnt Signaling Activation in Adipose Progenitors Promotes Insulin-Independent Muscle Glucose Uptake
Daniel Zeve et al.
CELL METABOLISM (2012)
Serum sclerostin levels were positively correlated with fat mass and bone mineral density in Central South Chinese postmenopausal women
Zhifeng Sheng et al.
CLINICAL ENDOCRINOLOGY (2012)
High Serum Sclerostin Predicts the Occurrence of Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
Aarthi Arasu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Association of Circulating Sclerostin Levels with Fat Mass and Metabolic Disease-Related Markers in Japanese Postmenopausal Women
Tomohiko Urano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition
Hiroyuki Mori et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The contribution of bone to whole-organism physiology
Gerard Karsenty et al.
NATURE (2012)
The skeleton as an endocrine organ
Douglas J. DiGirolamo et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men
Ulrike Il Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Specific metabolic rates of major organs and tissues across adulthood evaluation by mechanistic model of resting energy expenditure
ZiMian Wang et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Sclerostin: Current Knowledge and Future Perspectives
M. J. C. Moester et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Matthew T. Drake et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Common Variant in Low-Density Lipoprotein Receptor-Related Protein 6 Gene (LRP6) Is Associated With LDL-Cholesterol
Maciej Tomaszewski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION
Vaclav Veverka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage
Haiyan Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST
Mikhail V. Semenov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Polymorphisms of the low-density lipoprotein-receptor-related-protein-5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study
Yan-fang Guo et al.
JOURNAL OF MEDICAL GENETICS (2006)
Functional interaction between peroxisome proliferator-activated receptor γ and β-catenin
Jiajian Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis
Constantinos Christodoulides et al.
JOURNAL OF CELL SCIENCE (2006)
WNT10B mutations in human obesity
C Christodoulides et al.
DIABETOLOGIA (2006)
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
SFA Grant et al.
NATURE GENETICS (2006)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes
P Wei et al.
DIABETOLOGIA (2004)
Wnt10b inhibits development of white and brown adipose tissues
KA Longo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage
QQ Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
High-throughput engineering of the mouse genome coupled with high-resolution expression analysis
DM Valenzuela et al.
NATURE BIOTECHNOLOGY (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Regulation of Wnt signaling during adipogenesis
CN Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway
EH Jho et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors
D Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13
RCJ Twells et al.
GENOMICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
